{"date":"2025-03-19","count":27,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6838-2025-03-19-2358-1w4z6lb","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2025-03-19","time":"23:58:22","subject":"公告本公司授權夥伴向加拿大衛生部申請眼部術後炎症和疼痛治療新藥APP13007上市查驗登記，獲收件許可","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2025-03-19 23:58，「公告本公司授權夥伴向加拿大衛生部申請眼部術後炎症和疼痛治療新藥APP13007上市查驗登記，獲收件許可」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2025-03-19-2318-31k7fd","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-19","time":"23:18:32","subject":"公告本公司收到新加坡Senectus公司通知行使Chondrochymal之授權選擇權","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2025-03-19 23:18，「公告本公司收到新加坡Senectus公司通知行使Chondrochymal之授權選擇權」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2025-03-19-1908-qrsqda","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-19","time":"19:08:10","subject":"公告本公司獨立董事辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2025-03-19 19:08，「公告本公司獨立董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2025-03-19-1855-vao4fy","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2025-03-19","time":"18:55:33","subject":"代本公司重要子公司Acepodia Biotech, Inc.公告董事會通過捐贈事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2025-03-19 18:55，「代本公司重要子公司Acepodia Biotech, Inc.公告董事會通過捐贈事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2025-03-19-1836-1ugmg2w","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2025-03-19","time":"18:36:16","subject":"代本公司重要子公司育世博生物科技股份有限公司公告114年度股東常會(董事會代行)重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2025-03-19 18:36，「代本公司重要子公司育世博生物科技股份有限公司公告114年度股東常會(董事會代行)重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2025-03-19-1836-12jb8ds","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2025-03-19","time":"18:36:00","subject":"公司113年底累積虧損達實收資本額二分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2025-03-19 18:36，「公司113年底累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2025-03-19-1835-14sxwx9","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2025-03-19","time":"18:35:33","subject":"公告本公司董事會通過113年年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2025-03-19 18:35，「公告本公司董事會通過113年年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2025-03-19-1835-tulf6t","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2025-03-19","time":"18:35:01","subject":"公告本公司董事會決議召開114年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2025-03-19 18:35，「公告本公司董事會決議召開114年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2025-03-19-1834-bwopfv","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2025-03-19","time":"18:34:13","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2025-03-19 18:34，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2025-03-19-1804-1bi2fou","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2025-03-19","time":"18:04:11","subject":"本公司受邀參加台新證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2025-03-19 18:04，「本公司受邀參加台新證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2025-03-19-1751-1h76hm2","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2025-03-19","time":"17:51:03","subject":"公告本公司內部稽核主管異動。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2025-03-19 17:51，「公告本公司內部稽核主管異動。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2025-03-19-1750-1r9wl8l","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2025-03-19","time":"17:50:16","subject":"公告本公司會計主管異動。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2025-03-19 17:50，「公告本公司會計主管異動。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2025-03-19-1749-1bkm0mx","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2025-03-19","time":"17:49:48","subject":"公告本公司代理發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2025-03-19 17:49，「公告本公司代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2025-03-19-1748-1ur6s63","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2025-03-19","time":"17:48:54","subject":"公告本公司財務長異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2025-03-19 17:48，「公告本公司財務長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2025-03-19-1746-1vhu1xi","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2025-03-19","time":"17:46:54","subject":"公告本公司發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2025-03-19 17:46，「公告本公司發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2025-03-19-1746-wr0tu2","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2025-03-19","time":"17:46:05","subject":"公告本公司總經理異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2025-03-19 17:46，「公告本公司總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4728-2025-03-19-1732-1vgucln","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2025-03-19","time":"17:32:55","subject":"澄清媒體報導。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2025-03-19 17:32，「澄清媒體報導。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2025-03-19-1646-1jm8xii","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2025-03-19","time":"16:46:16","subject":"公告本公司一年內累積處分同一有價證券達實收資本額百分之二十","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2025-03-19 16:46，「公告本公司一年內累積處分同一有價證券達實收資本額百分之二十」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-03-19-1618-176ncfp","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-03-19","time":"16:18:18","subject":"董事會決議修訂114年股東常會召集事由","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-03-19 16:18，「董事會決議修訂114年股東常會召集事由」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2025-03-19-1551-1lr27ea","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2025-03-19","time":"15:51:59","subject":"公告本公司113年度現金增資收足股款暨增資基準日","clause":"第44款","fact_date":"2025-03-19","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2025-03-19 15:51，「公告本公司113年度現金增資收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6999-2025-03-19-1546-1lnm66v","company_id":"6999","company":"瀚醫生技","market":"興櫃","industry":"生技醫療","date":"2025-03-19","time":"15:46:07","subject":"(更正)公告本公司董事會決議盈餘暨資本公積轉增資發行新股案","clause":"第9款","fact_date":"2025-03-18","cite_as":"公開資訊觀測站重大訊息：瀚醫生技（6999），2025-03-19 15:46，「(更正)公告本公司董事會決議盈餘暨資本公積轉增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6999-2025-03-19-1542-1dhnky6","company_id":"6999","company":"瀚醫生技","market":"興櫃","industry":"生技醫療","date":"2025-03-19","time":"15:42:45","subject":"(更正)公告本公司董事會通過113年度董事及員工酬勞分配案","clause":"第44款","fact_date":"2025-03-18","cite_as":"公開資訊觀測站重大訊息：瀚醫生技（6999），2025-03-19 15:42，「(更正)公告本公司董事會通過113年度董事及員工酬勞分配案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6999-2025-03-19-1539-ewk6it","company_id":"6999","company":"瀚醫生技","market":"興櫃","industry":"生技醫療","date":"2025-03-19","time":"15:39:31","subject":"(更正)公告本公司董事會決議召開114年股東常會相關事宜","clause":"第32款","fact_date":"2025-03-18","cite_as":"公開資訊觀測站重大訊息：瀚醫生技（6999），2025-03-19 15:39，「(更正)公告本公司董事會決議召開114年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6999-2025-03-19-1533-dtyg8o","company_id":"6999","company":"瀚醫生技","market":"興櫃","industry":"生技醫療","date":"2025-03-19","time":"15:33:13","subject":"(更正)公告本公司董事會決議股利分派","clause":"第31款","fact_date":"2025-03-18","cite_as":"公開資訊觀測站重大訊息：瀚醫生技（6999），2025-03-19 15:33，「(更正)公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-03-19-1400-sty414","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-03-19","time":"14:00:01","subject":"更正本公司113年度合併、個體財務報告附註部份資訊","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-03-19 14:00，「更正本公司113年度合併、個體財務報告附註部份資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6518-2025-03-19-1032-p67uuk","company_id":"6518","company":"康科特","market":"興櫃","industry":"生技醫療","date":"2025-03-19","time":"10:32:40","subject":"公告本公司內部稽核主管異動","clause":"第11款","fact_date":"2025-03-17","cite_as":"公開資訊觀測站重大訊息：康科特（6518），2025-03-19 10:32，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2025-03-19-0447-q72kzm","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-03-19","time":"04:47:59","subject":"代重要子公司Belite Bio, Inc公告董事會決議召開2025年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-03-19 04:47，「代重要子公司Belite Bio, Inc公告董事會決議召開2025年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}